Journal of the American Society of Echocardiography
Volume 23, Issue 2 , Pages 144-155 , February 2010

Patent Foramen Ovale: Echocardiographic Detection and Clinical Relevance in Stroke

  • Marco R. Di Tullio, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Marco R. Di Tullio, MD, Columbia University, College of Physicians & Surgeons, Division of Cardiology, 630 West 168th Street, New York, NY 10032.

References 

  1. Penther P. Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies. [article in French] Arch Mal Coeur Vaiss. 1994;87:15–21
  2. Schroeckenstein RF, Wasenda GJ, Edwards JE. Valvular competent patent foramen ovale in adults. Minn Med. 1972;55:11–13
  3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17–20
  4. Sweeney LJ, Rosenquist GC. The normal anatomy of the atrial septum in the human heart. Am Heart J. 1979;98:194–199
  5. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Mayo Clin Proc. 1999;74:862–869
  6. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47:440–445
  7. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49:797–802
  8. Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med. 2005;353:2361–2372
  9. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91:2785–2792
  10. Hanley PC, Tajik AJ, Hynes JK, Edwards WD, Reeder GS, Hagler DJ, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985;6:1370–1382
  11. Schneider B, Hanrath P, Vogel P, Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol. 1990;16:1000–1009
  12. Zabalgoitia-Reyes M, Herrera C, Gandhi DK, Mehlman DJ, McPherson DD, Talano JV. A possible mechanism for neurologic ischemic events in patients with atrial septal aneurysm. Am J Cardiol. 1990;66:761–764
  13. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18:1223–1229
  14. Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med. 1978;102:62–65
  15. Mattioli AV, Bonetti L, Aquilina M, Oldani A, Longhini C, Mattioli G. Association between atrial septal aneurysm and patent foramen ovale in young patients with recent stroke and normal carotid arteries. Cerebrovasc Dis. 2003;15:4–10
  16. Burger AJ, Jadhav P, Kamalesh M. Low incidence of cerebrovascular events in patients with incidental atrial septal aneurysm. Echocardiography. 1997;14:589–596
  17. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy. J Am Coll Cardiol. 2003;42:1066–1072
  18. Homma S, Di Tullio MR, Sacco RL. Patent foramen ovale and ischemic stroke. In:  Barnett HJ,  Mohr JP,  Stein BM, et al. editor. Stroke: pathophysiology, diagnosis and management. 3rd ed. Philadelphia: Churchill Livingstone; 1998;p. 1013–1024
  19. Buttignoni SC, Khorsand A, Mundigler G, Bergler-Klein J, Heger M, Zehetgruber M, et al. Agitated saline versus polygelatine for the echocardiographic assessment of patent foramen ovale. J Am Soc Echocardiogr. 2004;17:1059–1065
  20. Gin KG, Huckell VF, Pollick C. Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol. 1993;22:1994–2000
  21. Hamann GF, Schatzer-Klotz D, Frohlig G, Strittmatter M, Jost V, Berg G, et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology. 1998;50:1423–1428
  22. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740–1746
  23. Johansson MC, Helgason H, Dellborg M, Eriksson P. Sensitivity for detection of patent foramen ovale increased with increasing number of contrast injections: a descriptive study with contrast transesophageal echocardiography. J Am Soc Echocardiogr. 2008;21:419–424
  24. Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996;77:1202–1209
  25. Rodriguez CJ, Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Race-ethnic differences in patent foramen ovale, atrial septal aneurysm, and right atrial anatomy among ischemic stroke patients. Stroke. 2003;34:2097–2102
  26. Agmon Y, Khandheria BK, Meissner I, Gentile F, Whisnant JP, Sicks JD, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 1999;99:1942–1944
  27. Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation. 1991;83:817–821
  28. Teague SM, Sharma MK. Detection of paradoxical cerebral echo contrast embolization by transcranial Doppler ultrasound. Stroke. 1991;22:740–745
  29. Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke. 1993;24:1020–1024
  30. Jauss M, Kaps M, Keberle M, Haberbosch W, Dorndorf W. A comparison of transesophageal echocardiography and transcranial Doppler sonography with contrast medium for detection of patent foramen ovale. Stroke. 1994;25:1265–1267
  31. Karnik R, Stollberger C, Valentin A, Winkler WB, Slany J. Detection of patent foramen ovale by transcranial contrast Doppler ultrasound. Am J Cardiol. 1992;69:560–562
  32. Job FP, Ringelstein EB, Grafen Y, Flachskampf FA, Doherty C, Stockmanns A, et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol. 1994;74:381–384
  33. Klotzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology. 1994;44:1603–1606
  34. Di Tullio M, Sacco RL, Massaro A, Venketasubramanian N, Sherman D, Hoffmann M, et al. Transcranial Doppler with contrast injection for the detection of patent foramen ovale in stroke patients. Int J Card Imaging. 1993;9:1–5
  35. Nemec JJ, Marwick TH, Lorig RJ, Davison MB, Chimowitz MI, Litowitz H, et al. Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol. 1991;68:1498–1502
  36. Kerr AJ, Buck T, Chia K, Chow CM, Fox E, Levine RA, et al. Transmitral Doppler: a new transthoracic contrast method for patent foramen ovale detection and quantification. J Am Coll Cardiol. 2000;36:1959–1966
  37. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382–390
  38. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–1152
  39. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11–12
  40. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24:1865–1873
  41. de Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol. 1992;69:1316–1320
  42. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 1992;117:461–465
  43. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol. 1992;70:668–672
  44. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357:2262–2268
  45. Jones EF, Calafiore P, Donnan GA, Tonkin AM. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol. 1994;74:596–599
  46. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172–1179
  47. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?. Stroke. 2009;40:2349–2355
  48. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li MG, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke. 1994;25:582–586
  49. Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol. 1995;26:1030–1038
  50. Van CG, Schulze D, Cosyns B, Vandenbossche JL. Relation between patent foramen ovale and unexplained stroke. Am J Cardiol. 1993;71:596–598
  51. Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol. 2009;103:124–129
  52. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke. 1998;29:1322–1328
  53. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86:1902–1908
  54. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998;29:944–948
  55. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med. 2000;109:456–462
  56. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625–2631
  57. Fox ER, Picard MH, Chow CM, Levine RA, Schwamm L, Kerr AJ. Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. Am Heart J. 2003;145:730–736
  58. Bonati LH, Kessel-Schaefer A, Linka AZ, Buser P, Wetzel SG, Radue EW, et al. Diffusion-weighted imaging in stroke attributable to patent foramen ovale: significance of concomitant atrial septum aneurysm. Stroke. 2006;37:2030–2034
  59. Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Le Heuzey JY, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000;31:398–403
  60. Kizer JR. Patent foramen ovale and cryptogenic stroke. Am J Med. 2007;120:e13
  61. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr. 2004;17:231–233
  62. Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari's network: normal anatomic variant or risk factor for arterial embolic events?. J Am Coll Cardiol. 1995;26:203–210
  63. Lapostolle F, Borron SW, Surget V, Sordelet D, Lapandry C, Adnet F. Stroke associated with pulmonary embolism after air travel. Neurology. 2003;60:1983–1985
  64. Kasper W, Geibel A, Tiede N, Just H. Patent foramen ovale in patients with haemodynamically significant pulmonary embolism. Lancet. 1992;340:561–564
  65. Bansal RC, Marsa RJ, Holland D, Beehler C, Gold PM. Severe hypoxemia due to shunting through a patent foramen ovale: a correctable complication of right ventricular infarction. J Am Coll Cardiol. 1985;5:188–192
  66. Harpaz D, Motro M, Kaplinsky E, Vered Z. Right-to-left shunt through a patent foramen ovale caused by severe tricuspid regurgitation detected with color Doppler echocardiography. J Am Soc Echocardiogr. 1992;5:77–80
  67. Shapiro GC, Leibowitz DW, Oz MC, Weslow RG, Di Tullio MR, Homma S. Diagnosis of patent foramen ovale with transesophageal echocardiography in a patient supported with a left ventricular assist device. J Heart Lung Transplant. 1995;14:594–597
  68. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med. 1993;119:461–465
  69. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism?. Stroke. 1993;24:31–34
  70. Lethen H, Flachskampf FA, Schneider R, Sliwka U, Kohn G, Noth J, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol. 1997;80:1066–1069
  71. Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli From Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35:46–50
  72. Chaturvedi S. Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci. 1998;160:158–160
  73. Pezzini A, Del ZE, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34:28–33
  74. Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M, Factor V. Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis. 2003;14:261–268
  75. Lichy C, Reuner KH, Buggle F, Litfin F, Rickmann H, Kunze A, et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis. 2003;16:83–87
  76. Botto N, Spadoni I, Giusti S, it-Ali L, Sicari R, Andreassi MG. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke. 2007;38:2070–2073
  77. Belvis R, Santamaria A, Marti-Fabregas J, Leta RG, Cocho D, Borrell M, et al. Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis. 2007;18:537–542
  78. Meacham RR, Headley AS, Bronze MS, Lewis JB, Rester MM. Impending paradoxical embolism. Arch Intern Med. 1998;158:438–448
  79. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J. 1995;130:1083–1088
  80. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, van MG Lausanne Stroke With Paradoxal Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology. 1996;46:1301–1305
  81. Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol. 1999;15:57–64
  82. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407–2413
  83. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112:1063–1072
  84. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology. 2009;73:89–97
  85. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042–1050
  86. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444–1451
  87. Serena J, Marti-Fabregas J, Santamarina E, Rodriguez JJ, Perez-Ayuso MJ, Masjuan J, et al. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke. 2008;39:3131–3136
  88. Devuyst G, Bogousslavsky J, Ruchat P, Jeanrenaud X, Despland PA, Regli F, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology. 1996;47:1162–1166
  89. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376–2381
  90. Giroud M, Tatou E, Steinmetz E, Lemesle M, Cottin Y, Wolf JE, et al. The interest of surgical closure of patent foramen ovale after stroke: a preliminary open study of 8 cases. Neurol Res. 1998;20:297–301
  91. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999;100:II171–II175
  92. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139:753–760
  93. Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol. 2007;99:1316–1320
  94. Spies C, Timmermanns I, Reissmann U, van EJ, Schrader R. Patent foramen ovale closure with the Intrasept occluder: complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. Catheter Cardiovasc Interv. 2008;71:390–395
  95. Luermans JG, Post MC, Schrader R, Sluysmans T, Vydt T, Vermeersch P, et al. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study. Catheter Cardiovasc Interv. 2008;71:822–828
  96. Post MC, Luermans JG, Plokker HW, Budts W. Patent foramen ovale and migraine. Catheter Cardiovasc Interv. 2007;69:9–14
  97. Opotowsky AR, Landzberg MJ, Kimmel SE, Webb GD. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events. Am Heart J. 2009;157:867–874
  98. Morandi E, Anzola GP, Casilli F, Onorato E. Silent brain embolism during transcatheter closure of patent foramen ovale: a transcranial Doppler study. Neurol Sci. 2006;27:328–331
  99. Dorenbeck U, Simon B, Skowasch D, Stusser C, Gockel A, Schild HH, et al. Cerebral embolism with interventional closure of symptomatic patent foramen ovale: an MRI-based study using diffusion-weighted imaging. Eur J Neurol. 2007;14:451–454
  100. Spies C, Khandelwal A, Timmermanns I, Schrader R. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. Am J Cardiol. 2008;102:902–906
  101. Schoen SP, Boscheri A, Lange SA, Braun MU, Fuhrmann J, Kappert U, et al. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale. Heart. 2008;94:844–847
  102. Wohrle J, Kochs M, Spiess J, Nusser T, Hombach V, Merkle N. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies. Circulation. 2009;119:3002–3008
  103. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44:750–758
  104. Meier B. Catheter-based closure of the patent foramen ovale. Circulation. 2009;120:1837–1841
  105. Windecker S, Meier B. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!. Circulation. 2008;118:1989–1998
  106. Messe SR, Kasner SE. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close. Circulation. 2008;118:1999–2004
  107. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577–617
  108. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999;52:1622–1625
  109. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998;8:327–330
  110. Buzzi MG, Moskowitz MA. The pathophysiology of migraine: year 2005. J Headache Pain. 2005;6:105–111
  111. Schwedt TJ, Dodick DW. Patent foramen ovale and migraine–bringing closure to the subject. Headache. 2006;46:663–671
  112. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart. 2004;90:1315–1320
  113. Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache. 2007;47:1311–1318
  114. Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation. 2008;118:1419–1424
  115. Jesurum JT, Fuller CJ, Kim CJ, Krabill KA, Spencer MP, Olsen JV, et al. Frequency of migraine headache relief following patent foramen ovale “closure” despite residual right-to-left shunt. Am J Cardiol. 2008;102:916–920
  116. Luermans JG, Post MC, Temmerman F, Thijs V, Schonewille WJ, Plokker HW, et al. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine: a prospective observational study. Acta Cardiol. 2008;63:571–577
  117. Papa M, Gaspardone A, Fracasso G, Ajello S, Gioffre G, Iamele M, et al. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage. Am J Cardiol. 2009;104:434–439
  118. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke. 2006;37:430–434
  119. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) trial. A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397–1404
  120. Rodes-Cabau J, Mineau S, Marrero A, Houde C, Mackey A, Cote JM, et al. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale. Am J Cardiol. 2008;101:688–692

PII: S0894-7317(09)01157-2

doi: 10.1016/j.echo.2009.12.008

Journal of the American Society of Echocardiography
Volume 23, Issue 2 , Pages 144-155 , February 2010

Article Tools

* Image Usage & Resolution